SKIP TO CONTENT
30+/SKIN
← ACTIVESRECORD A-02FAMILY SIGNAL PEPTIDE

Palmitoyl Tripeptide-1

Palmitoyl Tripeptide-1 + Palmitoyl Tetrapeptide-7

ALSO — MATRIX SIGNAL PEPTIDE

A forgery, essentially. We hand the fibroblast a fake breakdown signal and it rebuilds.

WHERE WE SIT IN THE PUBLISHED RANGE2% ——— 8%
4%

We compound toward the middle of the published range, not the top of it. Past the point where the dose–response curve flattens, the extra percent buys irritation and nothing else.

IDENTITY & RATINGSB
INCIPalmitoyl Tripeptide-1 + Palmitoyl Tetrapeptide-7
FAMILYSignal peptide
MOL. WEIGHT578.8 g/mol
HOUSE CONC.4% w/w
pH WINDOW5 – 6.5
ACTS ATDERMIS
DEPTH400 – 2000 µm
ONSET12–16 WK
STABILITYSTABLE
TRIALS ON FILE2
IRRITATION INDEX1 / 10
STRATUM CORNEUMEPIDERMISDERMIS

The shaded band is the depth this molecule is understood to reach. Anything below it is out of scope, whatever the label says.

01

Mechanism

EVIDENCE GRADE B

Mimics a fragment of collagen I. The fragment reads to the fibroblast as damage; the fibroblast answers by depositing new matrix. Tetrapeptide-7 suppresses interleukin-6 in parallel.

HOUSE NOTES

  • Slowest active in the formulary and the one people quit first. The curve does not bend before week 12.
  • No known conflicts. This is the one active you can put next to anything.

MEASURED ENDPOINTS

Dermal echogenicity+18%
24 WKREF-02
Procollagen I expression+46%
6 WKREF-07

SUPPORTING RECORDS

  • Split-face, vehicle-controlled

    N=64 · 24 WK · INVESTIGATOR-BLIND

  • Ex vivo skin explant

    N=24 · 6 WK · N/A

02

Layering

CONFLICTS & PAIRINGS
DO NOT LAYER

No known conflicts. This one goes next to anything in the formulary, in any order, on any night.

03

Compounded into

1 FORMULAS
SPECIMEN MONOGRAPH. FIGURES AND RECORDS ARE ILLUSTRATIVE PLACEHOLDERS AND CITE NO REAL STUDY, AUTHOR OR JOURNAL. NOT MEDICAL ADVICE.
DEPTH 000%SEC